Marinus Pharmaceuticals, INC Form 4 insider transactions
Form 4: Marinus Pharmaceuticals CEO Scott Braunstein Receives Stock Options and Restricted Stock Units
Scott Braunstein, CEO of Marinus Pharmaceuticals, was granted stock options and restricted stock units (RSUs) on June 18, 2024, according to a recent SEC filing.
Scott Braunstein, Chairman and CEO of Marinus Pharmaceuticals, exercised stock options to acquire 50,000 shares of common stock on March 27, 2024.